 | • レポートコード：GIR-22F19367 • 出版社/出版日：GlobalInfoResearch / 2022年11月 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Gynecological Progestin Drugs Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社の最新の調査によると、世界の婦人科用プロゲスチン薬物の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 婦人科用プロゲスチン薬物市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次をカバーします。 ・プロゲステロン、ジドロゲステロン、その他 アプリケーション別セグメントは次のように区分されます。 ・病院調剤薬局、小売調剤薬局、オンライン調剤薬局 世界の婦人科用プロゲスチン薬物市場の主要な市場プレーヤーは以下のとおりです。 ・Merck、Teva Generics、Besins Healthcare、Virtus Pharmaceuticals, LLC、BionPharma、Aquatic Remedies、Zhejiang Xianju Pharmaceutical、Zhejiang Aisheng Pharmaceutical、Zhejiang Medicine、Hubei Dongxin Pharmaceutical、Tianjin Jinyao Pharmaceutical、Guangzhou Baiyunshan Mingxing Pharmaceutical 地域別セグメントは次の地域・国をカバーします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、婦人科用プロゲスチン薬物製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な婦人科用プロゲスチン薬物メーカーの企業概要、2019年～2022年までの婦人科用プロゲスチン薬物の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な婦人科用プロゲスチン薬物メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別婦人科用プロゲスチン薬物の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの婦人科用プロゲスチン薬物のタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での婦人科用プロゲスチン薬物市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および婦人科用プロゲスチン薬物の産業チェーンを掲載しています。 ・第13、14、15章では、婦人科用プロゲスチン薬物の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - 婦人科用プロゲスチン薬物の概要 - タイプ別分析（2017年vs2021年vs2028年）：プロゲステロン、ジドロゲステロン、その他 - アプリケーション別分析（2017年vs2021年vs2028年）：病院調剤薬局、小売調剤薬局、オンライン調剤薬局 - 世界の婦人科用プロゲスチン薬物市場規模・予測 - 世界の婦人科用プロゲスチン薬物生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Merck、Teva Generics、Besins Healthcare、Virtus Pharmaceuticals, LLC、BionPharma、Aquatic Remedies、Zhejiang Xianju Pharmaceutical、Zhejiang Aisheng Pharmaceutical、Zhejiang Medicine、Hubei Dongxin Pharmaceutical、Tianjin Jinyao Pharmaceutical、Guangzhou Baiyunshan Mingxing Pharmaceutical ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：プロゲステロン、ジドロゲステロン、その他 ・アプリケーション別分析2017年-2028年：病院調剤薬局、小売調剤薬局、オンライン調剤薬局 ・婦人科用プロゲスチン薬物の北米市場分析 - 婦人科用プロゲスチン薬物の北米市場：タイプ別市場規模2017年-2028年 - 婦人科用プロゲスチン薬物の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・婦人科用プロゲスチン薬物のヨーロッパ市場分析 - ：婦人科用プロゲスチン薬物のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：婦人科用プロゲスチン薬物のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・婦人科用プロゲスチン薬物のアジア太平洋市場分析 - 婦人科用プロゲスチン薬物のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 婦人科用プロゲスチン薬物のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・婦人科用プロゲスチン薬物の南米市場分析 - 婦人科用プロゲスチン薬物の南米市場：タイプ別市場規模2017年-2028年 - 婦人科用プロゲスチン薬物の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・婦人科用プロゲスチン薬物の中東・アフリカ市場分析 - 婦人科用プロゲスチン薬物の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 婦人科用プロゲスチン薬物の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Gynecological Progestin Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Gynecological Progestin Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospital Pharmacies accounting for % of the Gynecological Progestin Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Progesterone segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Gynecological Progestin Drugs include Merck, Teva Generics, Besins Healthcare, Virtus Pharmaceuticals, LLC, and BionPharma, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Gynecological Progestin Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Progesterone
Dydrogesterone
Others
Market segment by Application can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
The key market players for global Gynecological Progestin Drugs market are listed below:
Merck
Teva Generics
Besins Healthcare
Virtus Pharmaceuticals, LLC
BionPharma
Aquatic Remedies
Zhejiang Xianju Pharmaceutical
Zhejiang Aisheng Pharmaceutical
Zhejiang Medicine
Hubei Dongxin Pharmaceutical
Tianjin Jinyao Pharmaceutical
Guangzhou Baiyunshan Mingxing Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gynecological Progestin Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gynecological Progestin Drugs, with price, sales, revenue and global market share of Gynecological Progestin Drugs from 2019 to 2022.
Chapter 3, the Gynecological Progestin Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gynecological Progestin Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Gynecological Progestin Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gynecological Progestin Drugs.
Chapter 13, 14, and 15, to describe Gynecological Progestin Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Gynecological Progestin Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Gynecological Progestin Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Progesterone
1.2.3 Dydrogesterone
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Gynecological Progestin Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Gynecological Progestin Drugs Market Size & Forecast
1.4.1 Global Gynecological Progestin Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Gynecological Progestin Drugs Sales in Volume (2017-2028)
1.4.3 Global Gynecological Progestin Drugs Price (2017-2028)
1.5 Global Gynecological Progestin Drugs Production Capacity Analysis
1.5.1 Global Gynecological Progestin Drugs Total Production Capacity (2017-2028)
1.5.2 Global Gynecological Progestin Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Gynecological Progestin Drugs Market Drivers
1.6.2 Gynecological Progestin Drugs Market Restraints
1.6.3 Gynecological Progestin Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Gynecological Progestin Drugs Product and Services
2.1.4 Merck Gynecological Progestin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Teva Generics
2.2.1 Teva Generics Details
2.2.2 Teva Generics Major Business
2.2.3 Teva Generics Gynecological Progestin Drugs Product and Services
2.2.4 Teva Generics Gynecological Progestin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Besins Healthcare
2.3.1 Besins Healthcare Details
2.3.2 Besins Healthcare Major Business
2.3.3 Besins Healthcare Gynecological Progestin Drugs Product and Services
2.3.4 Besins Healthcare Gynecological Progestin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Virtus Pharmaceuticals, LLC
2.4.1 Virtus Pharmaceuticals, LLC Details
2.4.2 Virtus Pharmaceuticals, LLC Major Business
2.4.3 Virtus Pharmaceuticals, LLC Gynecological Progestin Drugs Product and Services
2.4.4 Virtus Pharmaceuticals, LLC Gynecological Progestin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 BionPharma
2.5.1 BionPharma Details
2.5.2 BionPharma Major Business
2.5.3 BionPharma Gynecological Progestin Drugs Product and Services
2.5.4 BionPharma Gynecological Progestin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Aquatic Remedies
2.6.1 Aquatic Remedies Details
2.6.2 Aquatic Remedies Major Business
2.6.3 Aquatic Remedies Gynecological Progestin Drugs Product and Services
2.6.4 Aquatic Remedies Gynecological Progestin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Zhejiang Xianju Pharmaceutical
2.7.1 Zhejiang Xianju Pharmaceutical Details
2.7.2 Zhejiang Xianju Pharmaceutical Major Business
2.7.3 Zhejiang Xianju Pharmaceutical Gynecological Progestin Drugs Product and Services
2.7.4 Zhejiang Xianju Pharmaceutical Gynecological Progestin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Zhejiang Aisheng Pharmaceutical
2.8.1 Zhejiang Aisheng Pharmaceutical Details
2.8.2 Zhejiang Aisheng Pharmaceutical Major Business
2.8.3 Zhejiang Aisheng Pharmaceutical Gynecological Progestin Drugs Product and Services
2.8.4 Zhejiang Aisheng Pharmaceutical Gynecological Progestin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Zhejiang Medicine
2.9.1 Zhejiang Medicine Details
2.9.2 Zhejiang Medicine Major Business
2.9.3 Zhejiang Medicine Gynecological Progestin Drugs Product and Services
2.9.4 Zhejiang Medicine Gynecological Progestin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Hubei Dongxin Pharmaceutical
2.10.1 Hubei Dongxin Pharmaceutical Details
2.10.2 Hubei Dongxin Pharmaceutical Major Business
2.10.3 Hubei Dongxin Pharmaceutical Gynecological Progestin Drugs Product and Services
2.10.4 Hubei Dongxin Pharmaceutical Gynecological Progestin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Tianjin Jinyao Pharmaceutical
2.11.1 Tianjin Jinyao Pharmaceutical Details
2.11.2 Tianjin Jinyao Pharmaceutical Major Business
2.11.3 Tianjin Jinyao Pharmaceutical Gynecological Progestin Drugs Product and Services
2.11.4 Tianjin Jinyao Pharmaceutical Gynecological Progestin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Guangzhou Baiyunshan Mingxing Pharmaceutical
2.12.1 Guangzhou Baiyunshan Mingxing Pharmaceutical Details
2.12.2 Guangzhou Baiyunshan Mingxing Pharmaceutical Major Business
2.12.3 Guangzhou Baiyunshan Mingxing Pharmaceutical Gynecological Progestin Drugs Product and Services
2.12.4 Guangzhou Baiyunshan Mingxing Pharmaceutical Gynecological Progestin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Gynecological Progestin Drugs Breakdown Data by Manufacturer
3.1 Global Gynecological Progestin Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Gynecological Progestin Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Gynecological Progestin Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Gynecological Progestin Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Gynecological Progestin Drugs Manufacturer Market Share in 2021
3.5 Global Gynecological Progestin Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Gynecological Progestin Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Gynecological Progestin Drugs Market Size by Region
4.1.1 Global Gynecological Progestin Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Gynecological Progestin Drugs Revenue by Region (2017-2028)
4.2 North America Gynecological Progestin Drugs Revenue (2017-2028)
4.3 Europe Gynecological Progestin Drugs Revenue (2017-2028)
4.4 Asia-Pacific Gynecological Progestin Drugs Revenue (2017-2028)
4.5 South America Gynecological Progestin Drugs Revenue (2017-2028)
4.6 Middle East and Africa Gynecological Progestin Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Gynecological Progestin Drugs Sales in Volume by Type (2017-2028)
5.2 Global Gynecological Progestin Drugs Revenue by Type (2017-2028)
5.3 Global Gynecological Progestin Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Gynecological Progestin Drugs Sales in Volume by Application (2017-2028)
6.2 Global Gynecological Progestin Drugs Revenue by Application (2017-2028)
6.3 Global Gynecological Progestin Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Gynecological Progestin Drugs Sales by Type (2017-2028)
7.2 North America Gynecological Progestin Drugs Sales by Application (2017-2028)
7.3 North America Gynecological Progestin Drugs Market Size by Country
7.3.1 North America Gynecological Progestin Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Gynecological Progestin Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Gynecological Progestin Drugs Sales by Type (2017-2028)
8.2 Europe Gynecological Progestin Drugs Sales by Application (2017-2028)
8.3 Europe Gynecological Progestin Drugs Market Size by Country
8.3.1 Europe Gynecological Progestin Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Gynecological Progestin Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Gynecological Progestin Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Gynecological Progestin Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Gynecological Progestin Drugs Market Size by Region
9.3.1 Asia-Pacific Gynecological Progestin Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Gynecological Progestin Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Gynecological Progestin Drugs Sales by Type (2017-2028)
10.2 South America Gynecological Progestin Drugs Sales by Application (2017-2028)
10.3 South America Gynecological Progestin Drugs Market Size by Country
10.3.1 South America Gynecological Progestin Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Gynecological Progestin Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Gynecological Progestin Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Gynecological Progestin Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Gynecological Progestin Drugs Market Size by Country
11.3.1 Middle East & Africa Gynecological Progestin Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Gynecological Progestin Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Gynecological Progestin Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Gynecological Progestin Drugs
12.3 Gynecological Progestin Drugs Production Process
12.4 Gynecological Progestin Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Gynecological Progestin Drugs Typical Distributors
13.3 Gynecological Progestin Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer